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Purpose: To report the results of using prismatic glasses for Duane retraction syndrome (DRS).
Methods: Data were obtained from the records of patients who were evaluated during the 
year 2000 in the Strabismus Unit of the Beyoglu Eye Training and Research Hospital. The 
average follow-up was 12.2±17.7 months. In all cases, 2 main variables were evaluated: 
horizontal deviation in the primary position and face turn. Prismatic glasses were provided to 
patients according to the degree of shift in the primary position.
Results: The mean age of patients was 11.2 years. An analysis was performed on the data 
collected from 12 cases; 7 patients were females (58.3%) and 5 were males (41.7%), with 
11 (91.7%) cases being of type I DRS. All 12 patients had abnormal head posture (face turn) 
and an angle of mean deviation equaling 10 PD (prism dioptri).
Conclusion: Treatment was individualized on a case-by-case basis. Prismatic glasses are useful 
for eliminating abnormal head posture and ocular misalignment in selected cases.
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Introduction
Duane retraction syndrome (DRS) was recognized by Stilling in 1887 and Turk in 1896. 
Alexander Duane’s publication of Duane retraction syndrome (DRS) was in 1905. As 
a result, DRS is also referred to in the literature as Stilling-Turk-Duane Syndrome.1 
DRS is characterized by the following main features: 1) complete or partial absence of 
abduction of the affected eye; 2) partial, or rarely complete, deficiency of adduction of 
the affected eye; and 3) retraction of the affected eye into the orbit on adduction. More 
recently, these characteristics have been named as congenital cranial dysinnervation 
disorders (CCDDs) in the literature.
DRS is a paradoxic innervation of the lateral rectus (LR) during adduction. It is 
usually diagnosed early in childhood. Electromyography (EMG) studies of patients 
with DRS have shown that there is gross abnormality of the innervational pattern in 
this condition. Using EMG, Huber2 classified DRS into 3 types:
•	 Type I: Abduction restriction, normal or restricted adduction with associated retrac-
tion of the globe, and widening of the palpebral fissure on attempted abduction.
•	 Type II: Restricted adduction and abduction and retraction of the globe on adduc-
tion, frequently associated with exotropia.
•	 Type III: Severe restriction of both abduction and adduction, with either minimal 
esotropia orexotropia or near orthophoria and retraction on adduction and widening 
of the palpebral fissure on abduction.
The aims of treatment for DRS are to achieve eye alignment in the primary position, 
to eliminate abnormal head posture (AHP), and to prevent amblyopia. Some patients 
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do not require surgical correction because they have neither 
great deviation nor face turn. In this study, we describe the 
results of our medical treatment of DRS patients.
Methods
This study was retrospective and observational. All charts 
of the patients who were seen at our Hospital’s Strabismus 
Department between 2000 and 2015 and who were given a 
diagnosis of DRS were reviewed. Written informed consent 
was obtained from all patients or patients’ families. This 
study was in compliance with the principles of the Decla-
ration of Helsinki and was conducted in accordance with 
Beyoglu Göz Training and Research Hospital Institutional 
Review Board regulations.
Patients with DRS who underwent medical treatment 
with prismatic glasses and who had a minimum follow-up of 
3 months were included in the study. Patients were excluded 
if they had ,3 months of follow-up.
All patients underwent complete ophthalmologic and 
orthoptic examinations. The following information was 
recorded: age, sex, family history of strabismus, systemic 
disease, refractive status, presence or absence of amblyopia, 
AHP, and history of strabismus surgery.
Ocular alignment was graded as follows: orthotropia, 
with no movements noted on cover–uncover test; small-angle 
eso- or exodeviation, with phoria or tropia within 10 PD 
(prism dioptri) and significant eso- or exotropia, with devia-
tion .10 PD. Ocular misalignment data were obtained using 
the prism cover test and Krimsky test. This management 
has been suggested for patients who do not want botulinum 
toxin A or surgery, in addition to having a small deviation 
and AHP.
Ductions were graded on a scale from 0 (full duction) 
to -4 (indicating an inability to move the eye past the 
midline). Head-turn measurements were recorded and 
evaluated at distance and at near fixation with best optical 
corrections. An estimation of AHP was arrived at by an 
orthoptic method (the nose being the focus), photographed, 
and the patient’s distance- and near-reading positions 
observed.
The head turn is usually toward the affected eye for 
type 1 patients. Noses were used to evaluate the AHP, and 
patients were separated into 2 groups with AHP, namely, 
those with ,10° and .10° face turn. Palpebral fissures were 
investigated for retraction in adduction in all patients. At the 
same time, the upshoot or downshoot of the affected eye was 
assessed in adduction.
Stereoacuity for near vision was recorded using the 
Titmus Fly Stereo Test for all patients. All patients were 
treated with appropriate prismatic prescriptions and evaluated 
at 1 month and 3 months.
Data were analyzed using Minitab Statistical Software, 
release 20 (Minitab Inc, State College, PA, USA). A paired 
t-test was used for analysis. Statistical significance was 
defined at a level of P,0.05.
Results
A total of 638 records of strabismus patients diagnosed 
with DRS were available for review. Of these, 12 patients 
met the study inclusion criteria. The study group consisted 
of 7 (58.3%) girls and 5 (41.7%) boys. The mean age at 
presentation was 11.2 years (range: 5–20 years). The left 
eye was involved in 7 patients (66.7%) and for 1 patient, the 
condition was bilateral (8.3%). Type 1 DRS was identified 
in 11 (91.7%) patients.
All patients had hyperopia and only 1 had amblyopia. 
AHP was evaluated; 8 (66.7%) patients had ,10°, 4 (33.3%) 
patients had .10° face turn. The mean follow-up period 
was 12.2±17.7 months (range: 3–48 months). Orthophoria 
was seen in 10 (88.3%) patients. Esotropia was measured in 
2 (16.7%) patients at near and distance fixation upon admis-
sion. The mean esodeviations were 12 PD and 10 PD at near 
and distance fixation, respectively. All our patients had AHP 
(face turn). At the same time, our patient’s palpebral fissures 
were normal and equal on both sides in the primary position. 
Upshoot or downshoot was not observed.
At the patients’ 3-month clinical examinations, ocular 
misalignment in the primary position was found to have been 
eliminated with prismatic glasses in 12 patients. AHP disap-
peared completely in 5 patients, and had reduced in 7 patients. 
The patients’ stereoacuity was reasonably good.
This study reports the results of medical management 
using prismatic glasses to treat patients with DRS.
Discussion
DRS is a congenital disease that may affect the eyes uni-
laterally or bilaterally. The prevalance is 2%–4% among 
all patients with strabismus. In the general population, the 
prevalence of DRS is about 1/1,000.1 DRS prevalence was 
1.2% in the strabismus patients included in our study. It 
occurs sporadically in 90% of cases and is inherited in a small 
percentage as an autosomal dominant disorder.3–6 Bilateral 
cases represent 15%–20% of all cases of DRS. This study 
found 8.3% of DRS patients with bilateral involvement.4,6–8
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DRS patients should receive individualized treatment 
according to the clinical manifestations observed. The aims 
of management in DRS include the elimination or improve-
ment of abnormal head position (face turn), the treatment of 
significant or slight ocular misalignment, the reduction of 
severe globe retraction, and the improvement of upshoots 
and downshoots.
Refractive error must be corrected in patients with DRS 
as the first step in medical treatment. The prevalence of 
amblyopia in DRS patients ranges from 3% to 48% in the 
literature.4,9,10 Amblyopia was found in only 1 patient (8.3%) 
in our study and we advised this patient occlusion therapy. 
O’Malley et al11 and Mohan et al12 reported amblyopia in 
14% of their study group. Corrective lenses or contact lenses 
are used to correct refractive errors, and standard occlusion 
therapy is used to treat amblyopia.13
The correction of hypermetropic refractive error in 
children may reduce the angle of strabismus and DRS symp-
toms. Kekunnaya et al14 demonstrated that, in 1 case, face 
turn and esotropia in the primary position were eliminated 
with corrective lenses alone.
Park et al15 found in their study that orthotropia occurred 
in the majority (59%), followed by exotropia in 23.1%, and 
esotropia in 17.9%. Similarly, Isenberg and Urist’s study 
reported that 28% were esotropic, 29% were exotropic, and 
43% were orthotropic. Orthotropia was the most common 
primary position, and esotropia was found in only 2 (16.7%) 
patients in our study. Our patients with esotropia had 12 PD 
deviation in near vision and 10 PD in distance vision.
Strabismus can be called comitant or incomitant stra-
bismus based on whether deviation is equal in all positions 
of gaze or varies with the direction of gaze.16 Concomitant 
strabismus includes conditions such as palsy of the 4th and 
6th cranial nerves, DRS, Brown syndrome, inferior oblique 
overaction, as well as “A” and “V” patterns. Orthoptic vision 
therapy is a treatment alternative in DRS patients. The goal 
of the orthoptic treatment is the strongest possible fusion in 
primary gaze, as well as maximization of both monocular 
and binocular accommodative skills, including amplitude 
and flexibility.
A major finding of this study was that prismatic lenses 
may improve AHP and ocular misalignment, especially in 
cases with small deviation and AHP. Our study showed 
that prismatic glasses improved AHP completely in 41.6% 
of cases and reduced it to an acceptable level in 58.3% of 
the selected DRS patients. At the same time, we obtained 
improvement in ocular misalignment in the primary position. 
Therefore, prismatic improvement treatment is an alternative 
to surgery in these cases.
A surgical approach was required for a DRS patient with 
prominent ocular misalignment, marked AHP, cosmetically 
unacceptable upshoots and downshoot, and severe globe 
retraction on adduction. However, there is a possibility 
of treatment with prismatic glasses in selected patients if 
deviation is within 10 PD and AHP is 10°.
The total DRS patient sample size is the main strength of 
this study. However, the study group size is limited because 
only DRS patients with face turn ,10°, deviation #12 PD, 
and followed for at least 3 months in our clinic, were included 
in the study. Further study with wider case series and longer 
follow-up should be undertaken to support the results of 
this study.
Conclusion
To our knowledge, this study is the first study with the aim 
of presenting the treatment results of prismatic eyeglasses 
in patients with DRS.
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